Skip to content
2000
Volume 13, Issue 5
  • ISSN: 1567-2018
  • E-ISSN: 1875-5704

Abstract

Liver fibrosis is an important cause of morbidity and mortality worldwide and represent a difficult clinical challenge of global importance. The liver fibrosis progression needs to be controlled because persisted liver fibrosis can lead to liver cirrhosis or even hepatocellular carcinoma. Despite significant advances in the understanding of the liver fibrosis development, the therapeutic effect of drugs used in liver fibrosis treatment is not sufficient. Today, nanotechnology has been considered as a potential tool for developing novel drug delivery systems for the improved imaging and various diseases, including liver fibrosis. In this article, we discussed the use of nanotechnology for the treatment and imaging of liver fibrosis.

Loading

Article metrics loading...

/content/journals/cdd/10.2174/1567201812666150907115404
2016-08-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/cdd/10.2174/1567201812666150907115404
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test